In 2009, the Food and Drug Administration rejected an artificial hip manufactured by Johnson & Johnson. However, the company continued to sell the hip replacement in Europe and marketed a related model stateside. More than 90,000 patients worldwide used these faulty devices, and resulted in painful corrective surgery for many. In the wake of an August 2010 recall and thousands of lawsuits, Johnson & Johnson has lost at least $3 billion.
Barry Meier is reporter for our partner The New York Times.